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Abbreviations
aPC  antigen presenting cell
BrhPP  Bromohydrin pyrophosphate
CtLa-4  Cytotoxic t lymphocyte-associated antigen-4
eRK  extracellular-signal-regulated kinase
MaPK  Mitogen-activated protein kinase
NF-κB  Nuclear factor ‘kappa-light-chain-enhancer’ of 
activated B-cells
PD-1  Programmed death-1
PI3 K  Phosphoinositide 3 kinase
Stat3  Signal transducer and activator of transcription 3
tLR  toll-like receptor
Introduction
Vγ9Vδ2 γδ t cells are the main subset of the 1–10 % of 
γδ t lymphocytes in the human blood and upon activation 
display characteristics of both the innate and the adaptive 
immune system. the innate immune properties of acti-
vated Vδ2 γδ t cells include phagocytosis/trogocytosis, 
cross-presentation of soluble antigen, antibody-dependent 
cell-mediated and natural killer (NK)-receptor-mediated 
cytotoxicity [1–6]. In contrast, characteristics of the adap-
tive immune system imply the necessity of two signals 
[t cell receptor (tCR) and co-stimulatory molecules] to 
induce proliferation or the need for tCR stimulation to 
enhance toll-like receptor (tLR) ligand-mediated cytokine 
Abstract the proliferation and interleukin-2 production 
of CD4+CD25− αβ t cells were inhibited in a cell-contact 
manner by Vδ2 γδ t cells. the transcription factor helios 
was constitutively expressed in about one-third of circu-
lating γδ t cells and was upregulated by CD28-signaling. 
Our data suggest that helios could serve as a marker for 
differential activation status rather than for regulatory t 
cells (treg). Our findings also indicate that the interac-
tion of CD86 on activated Vδ2 t cells and cytotoxic t 
lymphocyte-associated antigen-4 (CtLa-4) on activated 
αβ t cells mediated the suppression because the suppres-
sive effect was abolished by blocking the CD86:CtLa-4 
interaction. Pre-treatment of Vδ2 t cells with toll-like 
receptor 2 ligands enhanced phosphorylation of MaPKs, 
akt, and NF-κB and partially abrogated the suppres-
sive capacity, whereas on co-cultured responder t cells 
inhibitory molecules were downregulated and akt and 
NF-κB phosphorylation was restored. Our results suggest 
that the regulation of αβ t cell proliferation by activated 
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production [7–9]. Vδ2 γδ t cells recognize phosphoryl-
ated intermediates [phosphoantigens (Pag)] of the non-
mevalonate pathway in prokaryotes or the accumulation of 
Pag in the dysregulated mevalonate pathway in eukaryotes 
[10]. they also produce large amounts of interferon gamma 
(IFN-γ) and tumor necrosis factor alpha (tNF-α) and high 
levels of CCL5 (RaNteS) and CCL3 (MIP-1α) as well as 
cytolytic effectors, such as granzyme B [11]. Initially acti-
vated Vδ2 γδ t cells are poor producers of interleukin-2 
(IL-2). For proliferation, Vδ2 γδ t cells require either the 
endogenous production of IL-2 by antigen-stimulated CD4 
t cells or an exogenous supply of IL-2 [12]. Vδ2 γδ t 
cells comprise distinct populations distinguishable on the 
basis of surface markers, trafficking properties, and effec-
tor functions. CD45Ra/CD27-positive naive γδ t cells 
(tnaive) as well as CD45Ra-negative and CD27-positive 
central memory t cells (tCM) have the ability to home to 
secondary lymphoid organs and they lack immediate effec-
tor functions. In comparison, CD45Ra/CD27-negative 
effector-memory t cells (teM) and CD45Ra-positive and 
CD27-negative terminally differentiated effector memory t 
cells (teMRa) have the ability to home to sites of inflamma-
tion where they display immediate effector functions, such 
as cytokine production and cytotoxicity [13, 14].
In general, γδ t lymphocytes exhibit cross-regulatory 
interactions with other cells of the immune system, and 
they have been shown to fulfill both co-stimulatory and 
suppressive functions [15–17].
thymic-derived natural regulatory t cells (ntreg) reg-
ulate self-tolerance and prevent autoimmunity [18]. they 
highly express CD25, cytotoxic t lymphocyte-associated 
antigen-4 (CtLa-4/CD152) and the transcription factors 
forkhead box (Fox) P3 and helios [19–21]. FoxP3 acts 
as a transcriptional repressor of IL-2 and IFN-γ genes, 
which results in the suppressive capacity of treg on 
the proliferation of other cells [22]. In contrast to mice, 
FoxP3 expression in humans does not necessarily con-
fer regulatory function because transient FoxP3 expres-
sion can be induced after activation in peripheral non-
treg detected with FoxP3 antibody PCh101 [21, 23, 24]. 
FoxP3 expression detected with anti-FoxP3 monoclonal 
antibody (mab) 259D is induced after γδ t cell activation 
in the presence of transforming growth factor beta (tGF-
β) and IL-15, a process which seems to be linked to sup-
pressive function [24–26]. Regarding FoxP3 expression 
stained with 259D mab, no data are available on Vδ2 γδ 
t cells activated with Pag- or anti-CD3/anti-CD28 mab 
in the absence of tGF-β and IL-15. the transcription 
factor helios is a member of the Ikaros family of DNa-
binding zinc finger regulators which includes Ikaros, aio-
los, eos, and Pegasus. helios is highly expressed in the 
earliest stage of t cell development [27]. In one study 
helios was reported to distinguish thymic-derived treg 
from peripherally induced FoxP3+ treg [20], but more 
recent studies have shown that helios can be up-regulated 
after activation in FoxP3+ itreg [adaptive FoxP3+CD4+ 
treg] as well as in human responder tCRαβ+ FoxP3− t 
cells [28–30]. Overexpression of dominant-negative or 
full-length helios isoforms alters the differentiation and 
activation of αβ t cells and also induces increased num-
bers of NK cells and γδ t cells in peripheral lymphoid 
organs [31]. In contrast, Cai et al. [32] reported that inac-
tivation of the helios gene by homologous recombination 
does not impair the effector function and differentiation 
of treg and αβ-, γδ-, and NKt cells, suggesting that the 
helios function can be compensated by other Ikaros fam-
ily members.
Inhibitory receptors such as CtLa-4 and programmed 
cell death (PD)-1 play a key role in immune regulation 
[33]. CtLa-4 is expressed on treg and upregulated upon 
tCR activation in non-treg. the higher affinity and avid-
ity of CtLa-4 for CD80 and CD86 expressed on anti-
gen-presenting cells (aPC) as compared to constitutively 
expressed co-stimulatory CD28 antagonize early t cell 
activation (mediated by CD28:CD80/CD86 interaction) 
and limit an immune response (by means of, for exam-
ple, decreased IL-2 production) [34, 35]. CD28 signaling 
results in a phosphoinositide 3 kinase (PI3 K)-dependent 
phosphorylation of the serine/threonine kinase akt and an 
activation of nuclear factor ‘kappa-light-chain-enhancer’ 
of activated B-cells (NF-κB), thereby influencing cell sur-
vival [36]. however, recent publications have discussed a 
dual function of CD28 and CtLa-4, both of which are 
expressed on treg and on non-treg, suggesting that both 
molecules are critical regulators of treg homeostasis and 
function [37]. PD-1 (CD279) is induced on tCR-activated 
t cells and delivers co-inhibitory signals upon binding to 
its ligands (L) PD-L1 (CD274) or PD-L2 (CD273). PD-
L1 is expressed on aPC as well as on t cells, whereas 
PD-L2 is inducibly expressed on dendritic cells (DC) and 
macrophages. Ligation of tCR and PD-1 induces tyros-
ine phosphorylation of PD-1 and recruitment of ShP-2, 
which dephosphorylates tCR proximal molecules (e.g., 
ZaP70, CD3ζ) and attenuates the tCR/CD28 signal [33, 
34, 38].
In earlier studies we demonstrated that human treg 
treated with tLR2 ligands lose their suppressive capac-
ity, which is based on a restoration of akt phosphoryla-
tion and downregulation of the cdk inhibitor p27Kip1 [39, 
40]. Recognition of bacterial lipopeptides by tLR1–tLR2 
or tLR2–tLR6 heterodimers results in the induction of 
signaling cascades which in turn activate NF-κB as well as 
mitogen-activated protein kinases (MaPK) [41, 42].
In the study reported here, we have examined the charac-
teristic features of suppressive Vδ2 γδ t cells and the molec-
ular mechanisms responsible for their suppressive function.




the Department of transfusion Medicine in Kiel, Germany 
provided leukocyte concentrates from healthy adult blood 
donors who gave their informed consent. the study was 
approved by the relevant institutional review boards (code 
number: D 405/10).
Isolation of t cell populations and cell cultures
Peripheral blood mononuclear cells (PBMC) were isolated 
from the leukocyte concentrates by Ficoll-hypaque (Bio-
chrom, Berlin, Germany) density gradient centrifugation. 
PBMC were screened for the expression of CD4, CD25high, 
and Vδ2 γδ t cells. PBMC with γδ t cells which consisted 
of only Vδ2 t cells were used; CD4+CD25− responder 
t cells and CD4+CD25high treg were purified from the 
PBMC using a magnetic cell separation system (Miltenyi 
Biotec, Bergisch-Gladbach, Germany). γδ t cells were 
isolated by positive selection (anti-tCRγ/δ MicroBead 
Kit; Miltenyi Biotec), and responder t cells by negative 
selection (CD4+ t Cell Isolation Kit II; Miltenyi Biotec) 
followed by the positive selection of treg by Dynabeads 
(Life technologies, Carlsbad, Ca). DetaChaBeaD 
(Life technologies) were used to remove magnetic parti-
cles from positively selected cells. Optimized separation 
conditions (e.g., usage of two consecutive MaCS col-
umns) revealed that the isolated t cell subpopulations had 
a purity of >98 %. to avoid (pre)activation, purified t cells 
were cultured in serum-free X-VIVO 15 medium (Lonza, 
Cologne, Germany) for 22 h at 37 °C in an incubator. Our 
previously published aPC-free suppression assay was 
applied as the read-out system for cell proliferation [43]. 
In brief, 104 purified responder t cells, 104 purified autol-
ogous γδ t cells or treg or the co-culture of responder t 
cells with treg or γδ t cells were stimulated with activa-
tion/expander t cell beads (a/e beads; Miltenyi Biotec) 
as a tCR stimulus in 96-well round-bottom plates. the 
a/e beads were coated with 10 μg/mL anti-CD3, 10 μg/
mL anti-CD28, and 0.5 μg/mL anti-CD2 mab. alterna-
tively, where indicated, cells were stimulated with 2 μg/
mL coated anti-CD3 mab (100 μL) or 1 μg/mL soluble 
anti-CD28 mab. to investigate the interaction of regula-
tory molecules between responder and γδ t cells, wells 
had been additionally pre-coated with of one of the follow-
ing antibodies (each at 5 μg/mL): anti-CD80 (clone 37711 
from R&D Systems, Wiesbaden, Germany), anti-CtLa-4 
(clone L3D10), anti-CD86 (clone It2.2), anti-PD-1 
(clone eh12.2h7), anti-PD-L1 (clone 29e.2a3) mabs 
and the appropriate isotype controls (all from Biolegend, 
San Diego, Ca). In γδ t cell solo-culture, 50 U/mL IL-2 
was added to ensure the proliferation of γδ t cells, which 
are poor IL-2 producers. the modulation of suppression 
by tLR2 ligands (tLR2L) was investigated after a 22 h 
pre-incubation of γδ t cells with a mixture of previously 
titrated lipopeptides [Pam2CSK4 (2 μg/mL), FSL-1 (1 μg/
mL), and Pam3CSK4 (2 μg/mL); tLR2-L-mix; InvivoGen, 
toulouse, France) followed by a washing step.
Cell proliferation assay
Proliferation was determined by the uptake of tritiated thy-
midine (3h-tdR) during the last 16 h of a 2- to 5-day cul-
ture period using a Wallac 1450 Microbeta trilux counter 
(Perkin elmer, Rodgau-Jügesheim, Germany). Results are 
expressed as mean counts per minute (cpm) ± standard 
deviation (SD) of triplicate cultures.
the absolute cell number of viable responder or γδ t 
cells was measured with a flow cytometric method termed 
the standard cell dilution assay (SCDa) after 6–8 days of 
culture [44]. Briefly, co-cultured responder and γδ t cells 
from 96-well round-bottom plates were washed and stained 
with fluorescein isothiocyanate (FItC)-labeled anti-CD4 
mabs (BD Biosciences, San Jose, Ca). after one wash-
ing step, cells were resuspended in sample buffer contain-
ing a defined number of allophycocyanin-labeled fixed 
standard cells and 0.2 μg/mL propidium iodide (PI). the 
standard cells were purified t cells that had been stained 
with allophycocyanin-labeled anti-hLa class I mab w6/32 
and anti-tCRαβ mab BMa031 and then fixed in 1 % para-
formaldehyde. the analysis on a flow cytometer enabled 
simultaneous measurement of the expansion of viable CD4 
t cells (FItC+PI−allophycocyanin−), viable γδ t cells 
(FItC−PI−allophycocyanin−), and standard cells (FItC−PI
+allophycocyanin+). Based on the known number of stand-
ard cells, we could then determine the absolute number of 
viable CD4+ responder t cells and γδ t cells in a given 
microculture well as described previously [44].
establishment of t cell lines
Positively isolated γδ t cells were cultured in RPMI 
1640 medium supplemented with 2 mmol/L l-glutamine, 
25 mmol/L hePeS, antibiotics, and 10 % fetal calf serum 
with the following supplements: (1) 300 nmol/L of phos-
phoantigen bromohydrin pyrophosphate (BrhPP; kindly 
provided by Innate Pharma, Marseille, France) plus 10 U/
mL IL-2; (2) BrhPP plus IL-2, 1.7 ng/mL tGF-β, and 
10 ng/mL IL-15; (3) a/e beads plus IL-2; (4) a/e beads 
plus IL-2, tGF-β, and IL-15. the cytokines were added 
once again on day 4, 8 and 12 after initial stimulation, and 
cells were split during the 16-day culture period. the purity 
of the expanded γδ t cells was >95 % 16 days after culture. 
Samples of 104 or 5 × 104 of the short-term cultured γδ t 
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cell lines were co-cultured with 104 or 5 × 104 autologous 
responder t cells, respectively, and re-stimulated with a/e 
beads or BrhPP with a mixture of Staphylococcus aureus 
enterotoxins a, B, C, D, and e (Serva, heidelberg, Ger-
many), 40 Gray autologous irradiated PBMC.
Flow cytometry and optical analysis
the following mab were used for intracellular staining: 
helios, FoxP3 (clones PCh101 and 259D), and the appro-
priate isotype controls [e-Bioscience (San Diego, Ca) and 
BioLegend (San Diego, Ca)]. PCh101 targets the N-termi-
nal region of a 431-amino acid protein, whereas 259D rec-
ognizes FoxP3 epitopes in the N-terminus of amino acids 
105–235 near the zinc finger region [21]. Both antibod-
ies recognize full-length and alternatively spliced human 
FoxP3. For intracellular staining, t cells were washed, 
fixed, and permeabilized using the kit of e-Biosciences 
(Staining Buffer Set no. 00-5523-00) according to the man-
ufacturer’s instructions.
Surface expression of CD25 was analyzed on responder 
t cells, treg, and γδ t cells after the cells were stained 
with anti-CD25 mab clone 2a3 (BD Biosciences).
Modulation of inhibitory and co-stimulatory molecules 
on the surface of responder or γδ t cells after co-culture and 
before and after stimulation with a/e beads was determined 
by using the following mab: anti-CD152 (CtLa-4, clone 
BNI3), anti-CD28 (clone L293), anti-PD1 (clone eh12.2h7), 
anti-PDL-1 (clone MIh1), anti-CD80 (clone L307.4), and 
anti-CD86 (clone 2331) (R&D Systems, Minneapolis, MN).
For the phosphorylation analysis of akt at S473 and 
t308, NF-κBp65 at S529, extracellular-signal-regu-
lated kinase (eRK) 1/2 at pt202/pY204, p38 MaPK at 
pt180/pY182, and Stat3 at Y705, we used the modified 
Phosflow™ Protocol III (BD Biosciences). Briefly, γδ t 
cells (2 × 105) pre-incubated with medium or a mixture of 
tLR2L for 22 h followed by a washing step were incubated 
with 2 μg/mL anti-CD3 (clone OKt3) mab and with 1 μg/
mL anti-CD28 mab for 30 min on ice. Cells were washed 
with ice-cold X-VIVO 15 medium, and stimulation was 
performed by cross-linking of anti-CD3/-CD28 mab with 
10 μg/mL rabbit-anti-mouse (rαm) immunoglobulin ab 
for different time periods at 37 °C. thereafter, cells were 
fixed with pre-warmed Cytofix™ Buffer (no. 554655; BD 
Biosciences) at 37 °C for 10 min, washed, permeabilized 
with Phosflow™ Perm Buffer III (no. 558050; BD Bio-
sciences) on ice for 30 min, washed, and stained with phy-
coerythrin (Pe)-conjugated anti-NF-κBp65 (pS529) clone 
K10-895.12.50, alexa Fluor 647-labeled mouse anti-phos-
pho-p38 MaPK (pt180/pY182) clone 36/p38, or anti-phos-
pho-akt-Ser473 clone M89-61 (all from BD Biosciences). 
all samples were analyzed on a FaCSCalibur flow cytom-
eter (BD Biosciences) using CellQuestPro software.
Statistical analysis
Student’s two-tailed t test (paired data) was used to analyze 
the statistical significance of differences.
Results
γδ t cells suppress expansion of responder t cells
Recently, we reported that activated human Vδ2-expressing 
γδ t cells negatively regulate the proliferative response of 
αβ t cells against antigens in the presence of IL-12-pro-
ducing DC or against strong recall antigens or alloantigens 
in the presence of aPC [17]. to examine whether freshly 
isolated γδ t cells also exert suppressive function on αβ 
t cells in the absence aPC, we used a previously estab-
lished aPC-free suppression assay [43]. this assay is based 
on the co-culture of magnetically purified CD4+CD25− 
responder t cells with CD4+CD25high FoxP3+ treg stimu-
lated with activation/expander t cell beads (a/e beads) in 
the absence of aPC. as illustrated in Fig. 1a, the expan-
sion of responder t cells was significantly, but not com-
pletely inhibited upon addition of graded numbers of γδ t 
cells, similar to the addition of treg. the proliferation of 
responder t cell clusters cultured alone (in solo-culture) 
compared to the co-culture with γδ t cells supported this 
observation, as shown in Fig. 1b. as expected, γδ t cells 
as well as treg did not expand after stimulation with a/e 
beads in the absence of responder t cells or exogenous 
IL-2 (Fig. 1a). at the 1:1 ratio, responder t cell prolifera-
tion was more potently suppressed by treg than by γδ t 
cells (Fig. 1a), possibly due to a reciprocal expansion of 
γδ t cells in co-culture with stimulated responder t cells 
producing IL-2. γδ t cells are poor IL-2 producers, and 
proliferation of γδ t cells in vitro depends on the endog-
enous IL-2 production of stimulated responder t cells or 
the exogenous supply of IL-2 [12, 17]. to address whether 
the suppression of responder t cell proliferation by γδ t 
cells was also accompanied by a reciprocal expansion 
of γδ t cells, we determined the absolute cell number of 
co-cultured responder t cells and γδ t cells. as shown in 
Fig. 1c, the reduction in the number of responder t cells 
in co-culture with γδ t cells compared to that of responder 
t cells in solo-culture (left part Fig. 1c) was accompanied 
by the simultaneous expansion of γδ t cells in co-culture 
with responder t cells (right part Fig. 1c). γδ t cell expan-
sion was also analyzed in the presence of exogenous IL-2, 
under which condition γδ t cells expanded, and in solo-
culture without IL-2, where γδ t cells did not proliferate 
[right part of Fig. 1c; electronic Supplementary Material 
(eSM) Fig. 1a]. to exclude the possibility that the γδ t 
cell-mediated suppression was due to the competition for 
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IL-2, we added 50 U/mL exogenous IL-2 to the suppres-
sion assay. addition of exogenous IL-2 led to enhancement 
of responder t cell expansion in their solo-culture, but after 
co-culture with γδ t cells responder t cell proliferation 
was still suppressed (eSM Fig. 1a). Moreover, trans-well 
experiments with responder and γδ t cells suggested a 
contact-dependent mechanism for the suppression because 
no suppression was observed in the majority of the tested 
donors after separation of the two t cell populations (eSM 
Fig. 1B). these results are supported by the observation 
Fig. 1  γδ t cells suppress 
responder t cell (Resp) prolif-
eration. 104 negatively isolated 
Resp (CD4+CD25-) were 
co-cultured at the indicated 
ratio with positively isolated 
γδ t cells (γδ) or regulatory 
t cells (Treg). the cells were 
stimulated with t cell a/e 
beads coated with 0.5 μg/mL 
anti-CD2, 10 μg/mL anti-CD3, 
and 10 μg/mL anti-CD28. a 
Proliferation was measured by 
tritiated thymidine (3H-TdR) 
incorporation after 3 days of 
stimulation. Results are shown 
as relative proliferation in com-
parison to solo-cultured Resp, 
whose proliferation was set to 
100 %. Results are presented as 
the mean ± standard devia-
tion (SD) of four independent 
experiments with triplicate 
determinations. b Microscopic 
analysis of 7-day cell cultures 
(magnification ×50). c absolute 
cell number of viable Resp or 
γδ t cells in solo- or co-culture 
(1:1 ratio) was analyzed in 18 
different donors by the standard 
cell dilution assay (SCDa) after 
7 days of stimulation. Medium 
of solo cultivated γδ t cells was 
supplemented with 50 U inter-
leukin (IL)-2. the mean value 
of quadruplicate (solo-culture, 
co-culture) or triplicate (γδ 
solo-culture + IL-2) determina-
tion for each donor is depicted 
as one symbol. Black bars Mean 
values of the different experi-
ments, asterisks statistical sig-
nificance according to Students 
t test (*p ≤ 0.05; **p ≤ 0.01). d 
Cell death was measured 3 days 
after stimulation in 13 different 
donors by propidium iodide (PI) 
incorporation into cells. Rela-
tive responder suppression was 
defined as percentage reduction 
of absolute Resp number in co-
culture compared to solo-culture 
on day 7
1948 C. Peters et al.
1 3
that freshly isolated γδ t cells did not release suppressive 
cytokines, such as IL-10 and tGF-β, after stimulation with 
a/e beads and that the addition of anti-IL-10 or anti-tGF-β 
ab did not abolish the γδ t cell-mediated suppression of 
responder t cells (data not shown). 
to examine whether a subpopulation of Vδ2 γδ t cells 
exerts this suppressive capacity, we separated Vδ2 γδ t 
cells according to their CD27 expression into subpopu-
lations of CD27-positive cells (naïve, CM) and CD27-
negative cells (eM, teMRa), respectively. In contrast to 
CD27-negative cells, the majority of the CD27-positive 
cells co-expressed CD28 (data not shown). although the 
suppressive activity of CD27-positive cells was slightly 
higher than that of CD27-negative cells, we did not observe 
a significant difference in suppressive function between 
CD27-negative and CD27-positive cells (data not shown).
In further experiments, we analyzed whether cytotoxic 
activity of γδ t cells after initial stimulation with a/e 
beads was responsible for suppression, possibly due to 
induced cell death of responder t cells. however, we did 
not observe an increased number of dead cells after co-cul-
turing γδ t cells with responder t cells at the time point 
when suppression takes place (Fig. 1d). Moreover, suppres-
sion of responder t cells co-cultured with γδ t cells was 
not inhibited by the Fas–Fc fusion protein or neutralizing 
anti-Fas mab, nor by pan-caspase inhibitor zVaD-fmk 
(data not shown). this observation fits well with the results 
published by Klas et al. [45] showing that resting responder 
t cells are refractory to cell death for several days. addi-
tionally, tNF-RI-, tNF- BPII-, tRaIL-R1-, or tRaIL-
R2-Fc fusion proteins or h2O2 scavenger catalase had no 
effect on the abrogation of suppression (data not shown).
taken together, these results indicated that γδ t cells can 
suppress responder t cells after activation with a/e beads, 
also in the absence of aPC, but that stimulus with anti-
CD28 mab was necessary to induce the suppressive activ-
ity of the γδ t cells (data not shown).
Characteristic treg markers are not expressed on γδ t cells
to obtain more insight into the phenotype of suppressive Vδ2 
γδ t cells, we analyzed putative treg markers such as helios, 
FoxP3 (with the clone PCh101 or 259D), and CD25 in/on 
freshly isolated γδ t cells (Fig. 2a). as negative and posi-
tive controls, we used freshly isolated responder t cells and 
freshly isolated treg, respectively. as expected, responder t 
cells did not express any of the tested putative treg mark-
ers, while freshly isolated treg were strongly positive for all 
markers (Fig. 2a). Intracellular FoxP3 as well as CD25 on 
the cell surface were not expressed by freshly isolated γδ t 
cells, while one-third of the γδ t cells expressed intracellular 
helios (Fig. 2a, [46]). the percentage of freshly isolated γδ 
t cells co-expressing CD27 and helios was very weak at day 
0, but it increased after stimulation with a/e beads (Fig. 2b). 
In subsequent time course experiments over several days, we 
investigated whether helios or FoxP3 expression was modu-
lated after the stimulation of γδ t cells, responder t cells, or 
co-cultured responder/γδ t cells by a/e beads (Fig. 2c, d). 
Interestingly, the mean fluorescence intensity of intracellu-
lar helios expression was significantly upregulated after γδ 
t cell stimulation when cells were solo-cultured but upregu-
lated to a lesser extent when the cells were co-cultured with 
responder t cells. In contrast, responder t cells virtually did 
not upregulate helios expression. the determination of the 
relative percentage revealed that about one-half of the a/e 
beads-stimulated γδ t cells co-expressed helios and CD27 
and that nearly 90 % of helios expressing γδ t cells were 
CD27 positive, which was independent of responder t cells 
presence (Fig. 2b, c). after stimulation, FoxP3 expression, 
as detected with the PCh101 mab, was enhanced under all 
culture conditions but most efficiently in responder t cells 
in solo culture. In contrast, when the 259D mab was used, 
FoxP3 expression was neither increased in responder t cells 
nor in γδ t cells (Fig. 2c). We concluded from these data that 
freshly isolated γδ t cells with a suppressive capacity dis-
play a different phenotype from that of ntreg. 
Inhibitory receptor–ligand interactions involved 
in suppressive functions of γδ t cells
Cytotoxic t lymphocyte-associated antigen-4 as well as PD-1 
and CD28 have been suggested as critical regulators of treg 
function [35]. We tested whether the interaction of inhibi-
tory and co-stimulatory cell surface molecules influences the 
interplay of co-cultured responder- and γδ t cells after activa-
tion with a/e beads. We observed that both t cell populations 
Fig. 2  expression of treg-associated markers by γδ t cells. a 105 
purified Resp, treg, or γδ t cells were stained with the indicated anti-
bodies. the expression of helios and FoxP3 was determined intracel-
lulary and CD25 expression on the cell surface by flow cytometry. 
For FoxP3 staining, two different anti-FoxP3 monoclonal antibodies 
(mab) were applied, as indicated. the small-sized dot-blots located in 
the upper left edge of the large-sized dot-blots show the isotype con-
trols. the numbers in the dot-blots represent the relative proportion. 
One representative out of five experiments is shown. b Co-expression 
of CD27 and helios was determined in a time-course study on/in a/e 
beads-stimulated γδ t cells. Mean values of the relative co-expression 
from three different donors are depicted in a bar chart. the co-expres-
sion on day 0 or 8 after stimulation is depicted for one representative 
donor in a dot-blot and for five different donors in a scatter plot. c, 
d. Changes in the expression of the analyzed transcription factors in 
solo- or co-cultured t cells after a/e beads-stimulation are displayed 
in a time-course study (c) or 7 days after stimulation (d). Solid lines 
Mean values of the mean fluorescence intensity of the indicated γδ- or 
responder t cells from at least three different donors cultured alone, 
dashed lines co-cultured cells. the mean fluorescence intensity of 
the appropriate isotype control was subtracted from that of the ana-
lyzed transcription factors [= difference (diff.) of median fluorescence 
intensity]
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upregulated CtLa-4 and PD-L1, whereas the median 
fluorescence of CD28 and PD-1 was mainly increased by 
responder t cells (Fig. 3). CD80 and CD86 mainly expressed 
by aPC were significantly upregulated by γδ t cells 3 days 
after activation with a/e beads, but not by responder t cells. 
to determine the nature of the suppressive effect, 
we used blocking antibodies to disrupt the interactions 
between CtLa-4:CD86, CtLa-4:CD80, or PD-1:PD-
L1, respectively. Blocking antibodies had only very weak 
effects on γδ t cell proliferation in comparison to the 
appropriate isotype controls. however, γδ t cell-mediated 
suppression of responder t cell proliferation was abolished 
by anti-CtLa-4, anti-CD86, or anti-PD-L1 mab, thereby 
blocking the CtLa-4 or PD-1 signal, respectively (Fig. 4). 
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these results suggested that CtLa-4 expressing responder 
t cells could be downregulated by the ligation of CD86 
expressed on γδ t cells, while PD–1 expressing responder 
t cells could be influenced by PD-L1-expressing-γδ t cells 
as well as by αβ t cells. anti-CD80 mab did not affect the 
interplay between responder t cells and γδ t cells, which 
can be explained by the weaker expression of CD80 on γδ 
t cells co-cultured with responder t cells than on those in 
solo-culture (Fig. 3; data not shown). 
tLR2 ligands partially abrogate the suppressive activity 
of γδ t cells
toll-like receptor 2 ligands are able to abrogate treg-
mediated suppression in vitro [39]. the inhibition of 
responder t cell proliferation was significantly reduced 
by the pre-treatment of γδ t cells with a mixture of 
the tLR2 ligands Pam2CSK4, Pam3CSK4, and FSL-1 
(Fig. 5a, responder). all freshly isolated γδ t cells as well 
as γδ t cell lines express tLR2 on the cell surface, as pre-
viously shown by us and other groups [11, 47]. Based on 
the finding that the pre-treatment of γδ t cells with tLR2 
ligands abolished suppressive activity, we analyzed the 
direct effects of tLR2 ligands on γδ t cells as well as the 
indirect effects of tLR2 ligand pre-treated γδ t cells on 
responder t cells. 
We determined that pre-treatment of γδ t cells with 
tLR2 ligands significantly enhanced their proliferative 
capacity in co-culture with responder t cells or after the 
addition of exogenous IL-2, but not in solo-culture in the 
Fig. 3  time course of the 
expression of inhibitory and co-
stimulatory surface molecules 
on co-cultured γδ t cells and 
Resp. 105 purified Resp and γδ 
t cells were co-cultured and 
stimulated by using t cell a/e 
beads for the indicated time 
points. the surface expression 
of the indicated inhibitory and 
co-stimulatory molecules was 
analyzed by flow cytometry in 
co-cultured Resp (filled circle) 
or in γδ t cells (filled triangle) 
over a time course. Symbols 
Mean values of differential 
median fluorescence intensity 
(isotype control was subtracted) 
of four different donors, 
asterisks statistical significance 
(*p ≤ 0.05; **p ≤ 0.01)
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absence of IL-2 (Fig. 5a; γδ t cells). the size and number 
of proliferation clusters of activated γδ t cells pre-treated 
with tLR2 ligands compared to untreated cells supported 
this observation (Fig. 5b). In additional experiments, we 
demonstrated that the IL-2 production of responder t cells 
was significantly impaired after co-culture with γδ t cells 
in the presence of a/e beads. however, pre-treatment of 
γδ t cells with tLR2 ligands significantly restored the 
reduced IL-2 production of the co-cultured responder t 
cells (eSM Fig. 2). In contrast to the reduced IL-2 pro-
duction measured in the suppression assay, IFN-γ, tNF-
α, CCL5 (RaNteS), and granzyme B production were 
not impaired, which might be due to the release of these 
mediators by γδ t cells. Pre-treatment with tLR2 ligands 
further significantly increased the production of granzyme 
B, IFN-γ, tNF-α, and IL-2 and also but not significantly 
of CCL5 (RaNteS). the produced mediators all together 
could positively influence the proliferation of responder t 
cells (eSM Fig. 2).
Importantly, the modulation of γδ t cell-mediated sup-
pression following pre-incubation with tLR2 ligands was 
associated with a modulation of expression of immune-
regulating cell surface molecules. the inhibitory recep-
tors CtLa-4 and PD-1 were downregulated on responder 
t cells, while their expression on treated γδ t cells was 
nearly the same as that of untreated cells (Fig. 5c). In 
contrast, the co-stimulatory CD28 molecule was sig-
nificantly upregulated in both cell populations after co-
culturing tLR2 ligand-treated γδ t cells with responder 
t cells. CD86, which binds to CtLa-4 and to CD28, as 
well as PD-L1 were significantly up-regulated in both cell 
populations after tLR2 ligand pre-treatment of γδ t cells 
Fig. 4  γδ t cell-mediated sup-
pression of Resp is modulated 
by blocking antibodies. 104 
purified γδ t cells were co-
cultured with 104 Resp. the t 
cells were stimulated with plate-
bound anti-CD3 (2 μg/mL) 
and soluble anti-CD28 (1 μg/
mL). to examine the influence 
of the interaction between the 
surface molecules shown on 
the presented scheme, we also 
coated the plates with the indi-
cated blocking antibodies (B) or 
the appropriate isotype controls 
(C) at a concentration of 5 μg/
mL. the absolute number of 
viable γδ t cells (γδ) or Resp 
was determined by the SCDa 
method on day 6 after stimula-
tion. Symbol Data of one donor, 
black bars mean value of at 
least six different experiments, 
asterisks statistical significance 
(*p ≤ 0.05; **p ≤ 0.01). ns 
Non-significant
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(Fig. 5c). helios expression was increased in pre-treated γδ 
t cells, whereas CD80 expression was not affected (data 
not shown).
these results suggested that γδ t cell-mediated suppres-
sion affected the proliferation of responder t cells as well 
as their production of IL-2, whereas the release of IFN-γ, 
tNF-α, MIP-1α, and RaNteS and granzyme B were not 
affected. Moreover, the addition of tLR2 ligands partially 
abolished the suppression by γδ t cells by downregulating 
indirectly inhibitory receptors on responder t cells.
Fig. 5  toll-like receptor 2 
ligands (TLR2-L) partially 
abrogate the γδ t cell-mediated 
suppression of Resp. 106 freshly 
isolated γδ t cells were pre-
incubated in the presence of 
medium or a tLR2-L mixture 
(2 μg/mL Pam2CSK4, 2 μg/
mL Pam3CSK4, and 1 μg/
mL FSL-1) for 22 h at 37 °C. 
thereafter, 104 γδ t cells or 
Resp were solo- (supplemented 
with 50 U IL-2 where indicated) 
or co-cultured. all cells were 
stimulated with t cell a/e 
beads. a the absolute number 
of viable Resp or γδ t cells was 
analyzed by the SCDa method 
7 days after stimulation. the 
mean value of quadruplicate 
(Resp solo-culture, co-culture) 
or triplicate (γδ solo-cul-
ture + IL-2) determination for 
each donor is presented as one 
symbol. Black bars Mean values 
of 18 different experiments. b In 
parallel, microscopic inspection 
of the medium-treated (γδ-Med) 
and tLR2-L-pre-incubated γδ 
t cells (γδ-TLR2-L) (magnifi-
cation ×50) is shown on day 
7 after stimulation. c Surface 
expression of the indicated 
molecules was analyzed on 
medium-treated (M) or tLR2-
L-pre-incubated (T) γδ and on 
co-cultured Resp t cells by flow 
cytometry at the time point of 
highest expression. Symbol Data 
of one donor, black bars mean 
value of at least five different 
experiments, asterisks statisti-
cal significance (*p ≤ 0.05; 
**p ≤ 0.01)
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tLR2 ligands enhance MaP kinases, NF-κB, and akt 
phosphorylation
We investigated whether enhanced cytokine production and 
proliferation after pre-treatment with tLR2 ligands had 
an influence on several signaling pathways in γδ t cells. 
tLR2 regulates NF-κB- and MaPK activity and possibly 
akt activity, thereby inducing the expression of cytokines 
and regulating cell survival and proliferation [41, 48]. We 
investigated the phosphorylation of those molecules shown 
in Fig. 6 in freshly isolated γδ t cells of several donors in a 
time course of 1–30 min by a sensitive Phosflow™ method. 
the time course of mean values from at least six donors is 
depicted in Fig. 6a, c. the phosphorylation in one donor 
(histogram) or at least six donors (scatter plot) at the time 
point of highest discrepancy between the stimulated, differ-
entially pre-treated cells (1 or 30 min) is shown in Fig. 6b, 
d. anti-CD3/anti-CD28 mab activation induced a rapid 
phosphorylation of akt at threonine 308 and of NF-κB at 
serine 529 after 1 min and the effect lasted for >30 min; 
this activation was enhanced significantly in tLR2 ligand-
treated γδ t cells in comparison to untreated γδ t cells. 
Phosphorylation of akt at serine 473 was not significantly 
enhanced in tLR2 ligand-treated γδ t cells (Fig. 6a, b). as 
a control, unstimulated γδ t cells in medium or with tLR2 
ligands were analyzed. 
additionally, we observed that the phosphorylation of 
eRK1/2, p38, and Stat3 at the indicated phosphorylation 
sites was induced 1 min after activation with anti-CD3/anti-
CD28 mab, but it was not increased by pre-treatment with 
tLR2 ligands. however, pre-treatment with tLR2 ligands 
significantly enhanced phosphorylation after 5–30 min 
compared to that of untreated γδ t cells (Fig. 6c, d). We 
obtained comparable results by Western blot analysis. 
Phosphorylation of eRK2 and p38 was enhanced 1 min 
after stimulation with anti-CD3/anti-CD28 and was further 
increased in tLR2 ligand pre-treated γδ t cells 5–30 min 
after activation in the case of eRK2 and p38 (eSM 
Fig. 3). Western blot was not as sensitive in detecting the 
phosphorylation of akt and NF-κB as the analysis by the 
Phosflow™ method, although a slightly increased phos-
phorylation of akt and NF-κB could be recognized after 
pre-treatment of γδ t cells with tLR2 ligands compared to 
untreated cells (eSM Fig. 3).
In subsequent experiments we took advantage of the 
Phosflow™ method to determine in parallel the phospho-
rylation of co-cultured responder t cells and γδ t cells. 
Responder t cells could be discriminated from γδ t cells 
by combining cell surface staining of the γδ tCR with 
intracellular anti-phospho akt or NF-κB mab. the co-
culture of responder t cells with γδ t cells significantly 
reduced the phosphorylation of akt (pt308 and pS473) 
and NF-κB in responder t cells. In co-culture with tLR2 
ligand pre-treated γδ t cells the inhibition of akt and NF-
κB phosphorylation was abrogated in responder t cells 
(eSM Fig. 4, upper panel). tLR2 ligand pre-incubation 
also enhanced akt and NF-κB phosphorylation in γδ t 
cells co-cultured with responder t cells, but only slightly in 
γδ t cells in solo-culture (eSM Fig. 4, lower panel).
In summary, the enhanced phosphorylation of MaP 
kinases, NF-κB, and akt might provide an explanation 
for the enhanced production of cytokines and an increased 
proliferation of responder t cells by γδ t cells after tLR2 
ligand treatment.
FoxP3 expression in γδ t cells does not correlate with their 
suppressive function
In previous studies using adoptive transfer of γδ t cells as 
an immunotherapeutic approach, freshly isolated γδ t cells 
were often expanded under different stimulation conditions 
(e.g., with Pag BrhPP + IL-2 or anti-CD3/anti-CD28 + 
IL-2) and, thereafter, cells were re-stimulated before trans-
fer to the patient. We focused on the question of whether 
BrhPP- or anti-CD3/anti-CD28-activated and -expanded 
γδ t cells are still able to suppress αβ t cell responses. 
Moreover, we analyzed if activated and expanded γδ t cells 
require tGF-β or IL-15 to exert suppressive activity. as 
shown in Fig. 7a, we observed that freshly isolated, posi-
tively selected γδ t cells cultured under the indicated ini-
tial stimulation conditions proliferated nearly to the same 
extent, with γδ t cells activated with BrhPP + IL-2 hav-
ing a slight advantage, even though the addition of tGF-β 
seemed to have a negative influence on proliferation inde-
pendently of the stimulus. Moreover, culture with BrhPP 
and tGF-β/IL-15 enhanced th1 cytokine production of 
γδ t cells (data not shown). the analysis of putative treg 
markers on γδ t cells cultured under these different con-
ditions indicated a very prominent expression of helios 
in γδ t cells stimulated with a/e beads, whereas BrhPP-
activated γδ t cells only slightly expressed helios. In fur-
ther experiments, we observed that the anti-CD28 mab 
stimulus was responsible for the induction of helios (eSM 
Fig. 5). Interestingly, only the γδ t cells cultured with 
tGF-β and IL-15 expressed FoxP3 (clone 259D), as shown 
in a time-course study over 8 days (Fig. 7b). FoxP3, but not 
helios expression, was transient and decreased in all γδ t 
cells 16 days after the initial stimulation and before they 
were co-cultured with responder t cells (Fig. 7b). after 
re-stimulation of γδ t cells with BrhPP, together with a 
very strong αβ t cell stimulus (a mixture of five different 
S. aureus enterotoxins), only γδ t cells initially stimulated 
with a/e beads + tGF-β and IL-15 were still able to sup-
press the expansion of freshly isolated responder t cells, 
although FoxP3 was no longer expressed (Fig. 7c). Inter-
estingly, the suppressive activity of these γδ t cells was 
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accompanied by increased Gata-3 expression (Fig. 7c). 
Moreover, γδ t cells initially stimulated with a/e beads 
alone still expressed helios, but were not suppressive after 
re-stimulation and released more th1 cytokines than γδ 
t cells initially stimulated with a/e beads + tGF-β and 
IL-15 (Fig. 7c; data not shown). In summary, the data sug-
gest that exclusive expression of FoxP3 or helios in γδ t 
cells does not correlate with their suppressive function. 
however, we did observe that the suppressive activity of γδ 
t cells was influenced through discernible stimulation con-
ditions, suggesting that enhancement of th1 cytokines in 
γδ t cells abolishes the suppressive capacity. 
Discussion
Our study has identified specific features of suppressive 
Vδ2 γδ t cells that differentiate them from ntreg. FoxP3 
and helios expression do not represent specific markers 
for the suppressive capacity of γδ t cells, but the expres-
sion of these molecules seems to be involved in the differ-
entiation of γδ t cells with regulatory function. We also 
provide insights into the suppressive mechanism of freshly 
isolated Vδ2 γδ t cells. We demonstrate an important role 
for the interaction of CD86 on γδ t cells and CtLa-4 on 
responder t cells which induces a reduced phosphoryla-
tion of akt and NF-κB. Furthermore, we show that the sup-
pressive mechanism of γδ t cells was abrogated by tLR2 
ligands, inducing a strong th1 response and abolishing the 
γδ t cell-mediated inhibition of akt and NF-κB phospho-
rylation in responder t cells (eSM Fig. 4).
Natural treg, which regulate peripheral tolerance, highly 
express CtLa-4 and CD25 and can be stained to the same 
extent with FoxP3 mab 259D and PCh101 [49]. In our 
assays, we investigated whether freshly isolated Vδ2 γδ t 
cells have characteristic features comparable to those of 
ntreg. We found that similar to ntreg, suppressive Vδ2 γδ 
t cells required activation, cell–cell contact, and IL-2 to 
exert their suppressive activity. In contrast to ntreg, how-
ever, freshly isolated Vδ2 γδ t cells did not express CtLa-
4, CD25, or intracellular FoxP3. after initial activation 
with a/e beads, cell surface CtLa-4 and CD25 as well as 
intracellular FoxP3 expression detected with PCh101 mab 
but not with 259D mab was upregulated on Vδ2 γδ t cells, 
similar to treg-depleted CD4+ responder t cells. the 
expression of FoxP3 detected with PCh101 mab but not 
with 259D mab has been demonstrated in responder t 
cells, but it did not coincide with the regulatory function of 
these cells [21]. In addition, the sensitivity of the 259D 
mab and the specificity of PCh101 mab in natural versus 
inducible treg is controversial; FoxP3 expression stained 
with PCh101 mab in responder t cells has been found not 
to correlate with regulatory function [21, 50–52]. We 
observed FoxP3 expression with the presumably more 
treg-specific FoxP3 mab 259D only in ntreg and in tGF-
β-induced γδ t cells, but only weakly in responder t cells 
or in freshly isolated Vδ2 γδ t cells in a resting as well as 
in an activated state. therefore, we conclude that Vδ2 γδ t 
cells do not possess a characteristic ntreg phenotype. how-
ever, initially activated Vδ2 γδ t cells suppressed co-cul-
tured responder t cells, although FoxP3 was not detected 
by the treg-specific 259D mab. Moreover, in accordance 
with the data of Casetti and colleagues [24], we observed 
that FoxP3 expression (stained with 259D mab) could be 
induced 2 days after the activation of Vδ2 γδ t cells under 
treg-inducing conditions (i.e., in the presence of tGF-β 
and IL-15) and that it increased over a 8-day period. In 
addition to the data of Casetti et al. [24], we demonstrated 
that the FoxP3 expression was transient and that it 
decreased 16 days after the initiation of solo-culture of γδ 
t cells. Subsequent co-culturing of FoxP3-negative Vδ2 γδ 
t cells initially expanded with a/e beads + tGF-β, and 
IL-15/IL-2 still suppressed responder t cell proliferation 
after re-stimulation (Fig. 7c). these results suggest that the 
expression of FoxP3 does not correlate closely with the 
suppressive activity of Vδ2 γδ t cells. Our observation that 
Vδ2 γδ t cells initially stimulated with a/e beads and 
tGF-β/IL-15/IL-2 were still suppressive under conditions 
that induced a strong th1 response in αβ t cells (after stim-
ulation with five different S. aureus enterotoxins) can be 
due to an upregulation of intracellular Gata-3 in these γδ 
t cells. the transcription factor Gata-3 controls the pro-
duction of immunoregulatory cytokines that could specifi-
cally counteract a th1 response. hansmann et al. [53] dem-
onstrated that human treg with a memory phenotype often 
downregulate FoxP3 after in vitro expansion. this down-
regulation can be accompanied by an upregulation of th2 
Fig. 6  Influence of tLR2-L on the phosphorylation of signal-
ing molecules in γδ t cells. 106 freshly isolated γδ t cells were 
medium-treated or pre-incubated with a tLR2-L-mixture (2 μg/
mL Pam2CSK4, 2 μg/mL Pam3CSK4, and 1 μg/mL FSL-1) for 
22 h at 37 °C. Cells were incubated for 30 min on ice with 2 μg/
mL anti-CD3 and 1 μg/mL anti-CD28. the stimulation was started 
by moving the tubes to 37 °C and the addition of rabbit anti mouse 
antibody (rαm) and stopped at indicated time points by cell fixation 
followed by permeabilization. Phosphorylated signaling molecules 
were labeled with specific fluochrome-conjugated antibodies and 
analyzed by flow cytometry. the median fluorescence intensity of 
anti-aKt (pt308, pS473), anti-nuclear factor ‘kappa-light-chain-
enhancer’ of activated B-cells (NF-κB/p65; pS529), anti-extra-signal-
regulated kinase (ERK1/2; pt202, pY204), anti-p38 (pt180, pY182), 
and anti-Stat3 (pY705) is depicted. a, c Mean values of the median 
fluorescence intensity of at least six donors over a time course of 
30 min. b, d Phosphorylation status at a given time point is presented 
in a histogram for one representative donor and for statistical analysis 
in a scatter plot including at least six different donors. Symbol Data of 
one donor, black bars mean value for six different experiments, aster-
isks statistical significance (*p ≤ 0.05; **p ≤ 0.01). MAPK Mitogen-
activated protein kinase
▴
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genes, such as Gata-3. Caccamo et al. [14] demonstrated 
that tCM γδ t cells produce less IFN-γ than teM γδ t cells. 
We observed that previously FoxP3-expressing Vδ2 γδ t 
cells, which were still suppressive after initial stimulation 
with a/e beads and tGF-β/IL-15/IL-2, co-expressed CD27 
and helios, whereas CD27 expression decreased in helios-
negative previously FoxP3-expressing Vδ2 γδ t cells after 
stimulation with BrhPP and tGF-β/IL-15/IL-2 (Fig. 7b; 
Fig. 7  expression of transcription factors and suppressive function of 
γδ t cells expanded under different culture conditions. a, b 5 × 104 
freshly isolated γδ t cells were stimulated with either 300 nM phos-
phoantigen bromohydrin pyrophosphate (BrHPP) (in the presence 
of 2.5 × 105 irradiated peripheral blood mononuclear cells) or a/e 
beads in the presence of 50 U/mL IL-2 or 1.7 ng/mL transforming 
growth factor beta (TGF-β), 10 ng/mL IL-15, and IL-2 as indicated. 
a Proliferation was determined by 3h-tdR incorporation after 5 days 
of culture. Mean ± SD of five independent experiments with tripli-
cate determination are shown. b Intracellular helios and FoxP3 (259D 
mab) expression was analyzed in a time course over 8 days and on 
day 16. Symbols Mean values of difference of median fluorescence 
intensity (isotype control was subtracted) of seven different donors. c 
5 × 104 γδ t cells activated under the above-mentioned culture condi-
tions (a) were expanded for 16 days after initial stimulation. there-
after, expanded cells were co-cultured with equal numbers of resting 
autologous responder t cells (1–4 in a). as a control for suppression, 
responder t cells were cultured alone (diagonally lined). all cell 
cultures were stimulated with BrhPP, and a mixture of five Staphy-
lococcus aureus enterotoxins. Proliferation of responder t cells was 
analyzed by SCDa 6 days after stimulation. Mean ± SD of five inde-
pendent experiments with quadruplicate determination are presented. 
In parallel the transcription factor Gata-3 was determined intracellu-
lary by flow cytometry in these γδ t cells co-cultured with autologous 
responder t cells
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data not shown). the latter observation could be interpreted 
as a differentiation of teM γδ t cells after stimulation with 
BrhPP and tGF-β/IL-15/IL-2. these data, together with 
the observation that in freshly isolated a/e beads-stimu-
lated Vδ2 γδ t cells the transcription factor helios was 
induced, suggest that CD27/helios-double positive tCM γδ 
t cells could be the suppressive subset within the Vδ2 γδ t 
cells. however, freshly isolated CD27-negative γδ t cells 
also had a suppressive capacity, although the suppression 
of freshly isolated CD27-positive γδ t cells was slightly 
higher compared to that of CD27-negative γδ t cells (data 
not shown). In this context, conflicting data exist on the 
function of helios. thornton and co-workers [20] described 
a selective expression of helios in murine treg derived 
from thymic origin, whereas helios was not expressed in 
itreg. however, recently published results demonstrate an 
upregulation of helios in murine and human itreg as well 
as an association of helios expression with t cell activation 
and cell division in non-treg cells [28–30]. Similar to the 
results of akimova and colleagues [28], we observed that 
<10 % of the freshly isolated human responder t cells 
expressed helios. however, a noteworthy upregulation of 
helios was not observed in responder t cells after activa-
tion with a/e beads in the absence or presence of co-cul-
tured Vδ2 γδ t cells. In contrast to responder t cells, 
helios was upregulated in Vδ2 γδ t cells cultured with 
IL-2 or co-cultured with IL-2-producing responder t cells 
2 days after stimulation with a/e beads. Upregulation of 
helios expression after the addition of IL-2 has been 
already described [28]. Our results provide evidence that 
the upregulation of helios was due to the stimulation of the 
Vδ2 γδ t cells with anti-CD28 mab, which was applied in 
nearly all experiments in combination with anti-CD3 mab 
to activate the Vδ2 γδ t cells. CD28 co-stimulation 
enhances the stability of IL-2 mRNa and, thereby, the tran-
scription and release of IL-2, which is necessary for t cell 
expansion as well as for regulatory t cell function, and it 
can also positively affect helios expression [33]. Studies by 
Verhagen and Wraith [54] on the generation of itreg from 
non-treg cells of Rag-deficient tg4 transgenic mice indi-
cate that a strong co-stimulus given by aPC but not by anti-
CD28 mab enhances helios expression. however, in our 
experiments with human γδ t cells, the addition of anti-
CD28 mab increased helios expression in activated γδ t 
cells, whereas it failed to induce a significant helios 
expression in CD4 t cells. CD28 signaling contributes to 
changes in DNa demethylation at the IL-2 gene locus, and 
helios interacts with histone deacetylases and methyl trans-
ferases within the nucleosome remodeling and deacetylase 
(NuRD) complex, which both influences chromatin remod-
eling that is required for the entry into the cell cycle and 
differentiation of cells and cell growth [55–58]. In terms of 
Vδ2 γδ t cells under different culture conditions in our 
study, we found that helios expression was more promi-
nent in Vδ2 γδ t cells stimulated with a/e beads (anti-
CD2/anti-CD3/anti-CD28) than in those stimulated by Pag 
BrhPP (in the presence of irradiated PBMC), whereas the 
proliferative activity was comparable. therefore, we could 
not conclude that helios was induced most prominently in 
highly dividing Vδ2 γδ t cells, as has been described for 
αβ t cells [28]. Furthermore, helios-expressing Vδ2 γδ t 
cells initially stimulated with a/e beads in the absence of 
tGF-β and IL-15 did not suppress responder t cells after 
re-stimulation, suggesting that helios expression in Vδ2 γδ 
t cells is not suitable as a marker for suppressive Vδ2 γδ t 
cells. this finding fits well with the studies of thornton and 
co-workers [20] who demonstrated that freshly expanded 
human itreg treated with helios siRNa had normal sup-
pressive activity. From our data, we cannot completely rule 
out that helios is involved in the suppressive activity, but 
we propose that helios could probably serve more as a 
marker of differential activation status of Vδ2 γδ t cells 
than as a treg-specific marker.
γδ t cells display a broad range of functional plasticity 
after activation, and Vδ2 γδ t cells can be differentiated on 
the basis of polarizing cytokines, homing receptors, and lin-
eage-determining transcription factors. Several recent pub-
lications have reported that Vδ2 γδ t cells can express an 
aPC-like phenotype after pre-activation for 18–48 h with 
Pag, autologous B cells, or irradiated hLa-a2-negative 
epstein–Barr virus-transformed B cell lines in the pres-
ence of IL-2 and IL-15, characterized by an upregulation 
of aPC-specific molecules and aPC function [1, 2, 59, 
60]. additionally, we observed that freshly isolated Vδ2 γδ 
t cells initially stimulated with a/e beads in the presence 
of IL-2 also upregulated CD86, PDL-1, CD80, and hLa-
DR (Fig. 3; data not shown). Moreover, we recognized 
that initially a/e beads-stimulated—but not (tLR2 ligand) 
pre-activated—Vδ2 γδ t cells exerted a suppressive capac-
ity. Our observation underlines the functional plasticity of 
Vδ2-expressing γδ t cells, which appears to be influenced 
by the activation status, the kind of stimulus of the cells, 
as well as by the surrounding cytokine milieu. the pres-
ence and the strength of co-stimulatory signals appear to 
be more important for suppression than the expression of 
specific suppressive markers. Freshly isolated γδ t cells 
exert their suppressive function only in the presence of 
anti-CD28 mab or of aPC [17]. CD28 and CtLa-4 are 
discussed as critical regulators of regulatory t cell homeo-
stasis and function. the dual function of CD28 enables the 
immune system to efficiently respond against microbes and 
at the same time to induce regulatory mechanisms required 
to terminate immune responses [37]. Moreover, our results 
revealed that CD86, which was upregulated on a/e beads-
activated Vδ2 γδ t cells, can bind to CtLa-4, which was 
upregulated on the activated responder t cells, because 
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the suppressive effect of Vδ2 γδ t cells was abrogated by 
blocking the CD86:CtLa-4 interaction between Vδ2 γδ t 
cells and responder t cells. anti-CD80 did not influence the 
interaction of Vδ2 γδ t cells and responder t cells, which 
can be explained by the low CD80 expression on Vδ2 γδ 
t cells co-culture with responder t cells. We used anti-
CD86 and CtLa-4 mab instead of CtLa-4-Fc to interrupt 
the CD86:CtLa-4 interaction on the basis of reports that 
CtLa-4-Fc could also result in reverse signaling through 
CD86/CD80 [61, 62]. We also examined a possible role 
of PD-1, which is another member of the CD28 family of 
receptors with inhibitory functions. PD-1 was upregulated 
on activated responder t cells to a higher extent than on Vδ2 
γδ t cells, and both cell populations expressed the ligand 
PD-L1, but not PD-L2 (Fig. 3; data not shown). these 
results suggest the possibility that responder t cells could 
be regulated by PD-L1 expressed by themselves or by γδ 
t cells. We observed that the suppressive effect of Vδ2 γδ 
t cells was abrogated by anti-PD-L1 antibodies, but only 
slightly by anti-PD-1 antibodies. One explanation for this 
discrepancy is the possible existence of an unknown second 
co-stimulatory receptor for PD-L1 in addition to the inhibi-
tory PD-1 [33]. the PD-1/PD-L1 pathway is described as 
a negative regulator of IFN-γ production, while CtLa-4 
inhibits IL-2 synthesis [33]. In our assays IFN-γ production 
was not decreased, although we cannot exclude the possibil-
ity that Vδ2 γδ t cells in the co-culture are the main pro-
ducer of IFN-γ, whereas IL-2 production is reduced after 
co-culturing Vδ2 γδ t cells with responder t cells. this 
possibility emphasizes the role of CtLa-4:CD86 in Vδ2 γδ 
t cell-mediated suppression on responder t cells.
While initially a/e beads-stimulated γδ t cells were 
suppressive, pre-treatment with tLR2 ligands partially 
abolished suppression and led to an enhanced phospho-
rylation of MaPKs, akt, and NF-κB resulting in a higher 
production of th1 cytokines. We and others have already 
described that anti-CD3 mab as well as Pag activation of 
γδ t cells induce phosphorylation of MaPK eRK2 and 
of p38 and akt (at serine 473), which in turn induce the 
upregulation of crucial target genes, such as IFN-γ and 
tNF-α [63–65]. Moreover, we observed in our study that 
combined stimulation with anti-CD3/anti-CD28 mab 
induced an additional phosphorylation of akt at threonine 
308 as well as of NF-κB and Stat3 in γδ t cells after stim-
ulation. NF-κB has been described to be involved in the 
induction of RaNteS, whereas Stat3 plays a key role in 
many cellular processes, such as cell growth [66]. In line 
with our previous report demonstrating that tLR2 ligands 
enhance tCR-mediated cytokine and chemokine produc-
tion of γδ t cells [11], we additionally found that tLR2 
ligands significantly increased the activation of MaPKs, 
NF-κB, Stat3, and akt at threonine 308. however, the more 
important question was what happens to the responder t 
cells in the presence of tLR2 ligand-pre-activated γδ t 
cells. We observed a downregulation of inhibitory mol-
ecules CtLa-4 and PD-1 on responder t cells. Concomi-
tantly, an enhancement of CD28 expression and an increase 
of effector function of responder t cells resulted in a partial 
abrogating of the Vδ2 γδ t cell-mediated suppression.
Our results suggest that the pre-activation of γδ t cells 
could induce aPC function of γδ t cells, but not their 
suppressive capacity. tLR2 ligand-pre-treated γδ t cells 
and γδ t cells of short-term lines are not able to suppress 
responder t cells which were activated with a mixture of 
five S. aureus enterotoxins that activate a greater th1-rep-
ertoire of responder t cells than only one S. aureus enter-
otoxin (as applied in our previous study [17]). It is well 
established that a mixture of S. aureus enterotoxins induces 
a massive cytokine release in responder t cells [67]. We 
observed that αβ t cells were able to produce high amounts 
of, for example, IL-6 after combined tCR/tLR stimula-
tion [8]. enhanced IL-6 production has been described to 
abrogate treg-mediated suppression of responder t cells 
in mice and humans [68, 69]. these results suggest that a 
bacterial infection (e.g., tLR ligand stimulation) could be 
a strategy to optimize a th1-mediated immune response, 
which results in an abrogation of suppressive capacity of 
γδ t cells. Only a/e beads, tGF-β, and IL-15-expanded γδ 
t cells which expressed Gata-3 and helios in co-culture 
were able to suppress responder t cell proliferation.
In conclusion, our data provide evidence that Vδ2 γδ t 
cells have an immunosuppressive potential in the presence 
of aPC [17] or after co-stimulation with anti-CD28 mab, 
which could be antagonized by tLR2-ligands or a massive 
th1 cytokine production by responder t cells. the ability 
to control responder t cells by suppressive γδ t cells could 
have major therapeutic potential for the control of autoim-
munity or allergic reactions. Moreover, elimination of sup-
pressive γδ t cells from cells used for adoptive transfer in 
cancer patients could be useful. 
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